Ardelyx (ARDX)
(Real Time Quote from BATS)
$6.18 USD
-0.24 (-3.74%)
Updated Sep 19, 2025 02:46 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/30/2025
Time: -- |
9/2025 | $-0.07 | -85.71% |
Earnings Summary
For their last quarter, Ardelyx (ARDX) reported earnings of -$0.08 per share, beating the Zacks Consensus Estimate of $-0.13 per share. This reflects a positive earnings surprise of 38.46%. Look out for ARDX's next earnings release expected on October 30, 2025.
Earnings History
Price & Consensus
Zacks News for ARDX
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates
ARDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Earnings Preview: Ardelyx (ARDX) Q2 Earnings Expected to Decline
Compared to Estimates, Ardelyx (ARDX) Q1 Earnings: A Look at Key Metrics
ARDX FAQs
Based on past history, Zacks believes Ardelyx, Inc. (ARDX) will report their next quarter earnings on October 30, 2025. For the next earning release, we expect the company to report earnings of -0.07 per share, reflecting a year-over-year increase of .
Based on past history, Zacks believes Ardelyx, Inc. (ARDX) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on October 30, 2025.
The Zacks Consensus Estimate for Ardelyx, Inc. (ARDX) for the quarter ending in September 2025 is $-0.07 a share. We expect Ardelyx, Inc. to miss by -85.71%.
In the earnings report for the quarter ending in September 2024, Ardelyx, Inc. (ARDX) announced earnings of $0.00 per share versus the Zacks Consensus Estimate of $-0.05 per share, representing a surprise of -100.00%.